Central diabetes insipidus induced by tuberculosis in a rheumatoid arthritis patient

Acta Reumatologica Portuguesa

Volumn 35, Issue 2, 2010, Pages 232-235

  Domiciano, Diogo Souza ^a   de Carvalho, Jozélio Freire ^a   Macedo, André Régis ^a   Laurindo, Ieda Maria Magalhães ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Diabetes insipidus; Nodulosis; Rheumatoid arthritis; Tuberculoma; Tuberculosis

Indexed keywords

ADULT; ARTICLE; CASE REPORT; FEMALE; HUMAN; HYPOPHYSIS DISEASE; MICROBIOLOGY; NEUROGENIC DIABETES INSIPIDUS; RHEUMATOID ARTHRITIS; TUBERCULOSIS;

ADULT; ARTHRITIS, RHEUMATOID; DIABETES INSIPIDUS, NEUROGENIC; FEMALE; HUMANS; PITUITARY DISEASES; TUBERCULOSIS, ENDOCRINE;

EID: 78650463073     PISSN: 0303464X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Porter JDH, McAdam KPWJ. The re-emergence of tuberculosis. Rev. Public Health 1994; 15: 303-323.
2. Gardam MA et al. Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management. Lancet Infect Dis 2003; 3: 148-155.
3. Winthrop KL. Risk and prevention of tuberculosis and other serious opportunistic infections associated with the inhibition of tumor necrosis factor. Nat Clin Pract Rheumatol 2006; 2: 602-610.
4. Bekker LG et al. TNF-a controls intracellular mycobacterial growth by both inducible nitric oxide synthase-dependent and inducible nitric oxide synthase-independent pathways. J Immunol 2001; 166: 6728-6734.
5. Keane J et al. Tuberculosis associated with infliximab, a tumor necrosis factor-a neutralizing agent. N Engl J Med 2001; 345: 1098-1104.
6. Sharma MC, Arora R, Mahapatra AK, Sarat-Chandra P, Gaikwad SB, Sarkar C. Intrasellar tuberculoma - an enigmatic pituitary infection: a series of 18 cases. Clin Neurol Neurosurg 2000; 102:72-77.
7. Hay DR. Diabetes insipidus after tuberculous meningitis. Br Med J 1960; 1: 707.
8. Giese A, Kucinsli T, Hagel C, Lohmann F. Intracranial tuberculomas mimicking a malignant disease in an immunocompetant patient. Acta Neurochir 2003; 145: 513-519.
9. Wasay M, Moolani MK, Zaheer J, Kheleani BA, Smego RA, Sarwari RA. Prognostic indicators in patients with intracranial tuberculoma: a review of 102 cases. J Pak Med Assoc 2004; 54: 83-87.
10. Bayindir C, Mete O, Bilgic B. Retrospective study of 23 pathologically proven cases of central nervous system tuberculomas. Clin Neurol Neurosurg 2006; 108: 353-357.
11. Emery P, Panayi G, Symmons D, Brown G. Mechanisms of depressed delayed-type hypersensitivity in rheumatoid arthritis: the role of protein energy malnutrition. Ann Rheum Dis 1984;4:430-434.
12. Pope RM, Kniker WT, Talal N, Dauphinee M. Delayed type hypersensitivity in patients with rheumatoid arthritis. J Rheumatol 1993;20:17-20.
13. Karam NE, Roger L, Hankins LL, Reveille JD. Rheumatoid nodulosis of the meninges. J Rheumatol 1994; 21: 1960-1963.
14. Jackson CG, Chess RL, Ward JR. A case of rheumatoid nodule formation within the central nervous system and review of the literature. J Rheumatol 1984; 11:237-240.
15. Bathon JM, Moreland LW, DiBartolomeo AG. Inflammatory central nervous system involvement in Rheumatoid Arthritis. Semin Arthritis Rheum 1989; 18: 258-266.